VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | +87.5% | 1,416 | +95.6% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 724 | -3.7% | 0.00% | – |
| Q4 2021 | $12,000 | 0.0% | 752 | +5.8% | 0.00% | – |
| Q3 2021 | $12,000 | +71.4% | 711 | +19.9% | 0.00% | -100.0% |
| Q2 2020 | $7,000 | -36.4% | 593 | -44.3% | 0.00% | -80.0% |
| Q1 2020 | $11,000 | +1000.0% | 1,064 | +1734.5% | 0.01% | – |
| Q2 2019 | $1,000 | -94.4% | 58 | -94.1% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | +800.0% | 984 | +720.0% | 0.01% | +250.0% |
| Q4 2017 | $2,000 | +100.0% | 120 | +103.4% | 0.00% | +100.0% |
| Q3 2017 | $1,000 | 0.0% | 59 | +20.4% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | -66.7% | 49 | -77.3% | 0.00% | -66.7% |
| Q4 2016 | $3,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |